S. 1498 (97th): A bill to establish an office in the National Institutes of Health to assist in the development of drugs for diseases and conditions of low incidence.


Jul 17, 1981
97th Congress, 1981–1982

Died in a previous Congress

This bill was introduced on July 17, 1981, in a previous session of Congress, but was not enacted.


Nancy Kassebaum

Senator from Kansas


About the bill

Summary (CRS)

7/17/1981--Introduced.Establishes within the National Institutes of Health the Office of Drugs of Limited Commercial Value under the direction of the Director of the National Institutes of Health. Establishes within the ... Read more >

The bill’s title was written by its sponsor.


Jul 17, 1981

This is the first step in the legislative process.

This is a Senate bill in the United States Congress (indicated by the “S.” in “S. 1498”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.


26 cosponsors (17D, 9R) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.


There have been no roll call votes related to this bill.

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

H.R. 1663 (identical)

Referred to Committee
Last Action: Feb 4, 1981

Search for similar bills.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Click a format for a citation suggestion: